Remission vs. Regulation: Discussing Options for Patients with Type 2 Diabetes
Recent evidence regarding diabetes remission has increased the number of options for patients with type 2 diabetes. This module describes the evidence for both remission and regulation of type 2 diabetes and provides an example of how clinicians can engage with patients to facilitate shared decision-making. The module also reviews how to individualize diabetes treatment according to patient values, preferences, and priorities.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Society of Endocrinology and Metabolism. You may claim a maximum of 1.0 hours (credits are automatically calculated).
Alice Cheng, MD, FRCPC
Celine Huot, MD, FRCPC
Upon successful completion of this continuing education module, the participant will be better able to:
- Discuss the evidence for remission of diabetes.
- Initiate diabetes treatment in newly-diagnosed patients with type 2 diabetes, according to the Diabetes Canada guidelines.
- Start a conversation with patients to enable shared decision making for treatment initiation.
- Individualize treatment according to patient concerns and priorities.